On 2026-07-13, Injective (INJ) is trading at $4.865626415367089, sitting roughly 90.8% below its all‑time high of $52.62. The token shows a bullish MACD histogram (+0.02414) while the 24‑hour change is +0.46% and the RSI reads 47.88, indicating neutral momentum. This snapshot captures a short‑term bounce amid a longer‑term downtrend from recent highs.
RSI near neutral (1.9/2), MACD bullish (1.5/1.5), volume slightly down (1.36/1.5), price above MA20/MA200 but below MA50 (1.33/2), weak fundamentals (0/1.5), tokenomics neutral (1.5/1.5).
Over the past week INJ has fallen 4.24% (from $4.8385), and over the last month it is down 11.22% (from $5.2193). However, looking back 90 days the price is up 42.01% from $3.2627, showing a medium‑term bearish correction within a longer‑term bullish backdrop. The recent decline appears to be a pull‑back rather than a reversal of the longer‑term upward trend.
The 24‑hour volume is $69,952,921.79, which is 9.61% below the 30‑day average volume of $77,391,262.87, reflecting a decreasing trend. Lower volume often suggests waning trader interest and can precede further price consolidation or a reversal. Despite the dip, the absolute volume remains substantial for a token of this market cap.
INJ’s volume‑to‑market‑cap ratio stands at 0.1438 (14.4%), calculated from a $69.95M 24h volume against a $486.55M market cap. This ratio sits within the typical healthy range for liquid assets (roughly 5‑20%), indicating that enough trading activity exists to support relatively smooth order execution. A ratio much higher could signal speculative frenzy, while much lower would warn of illiquidity.
The RSI is 47.88, firmly in the neutral zone (40‑60), suggesting neither overbought nor oversold conditions. MACD shows a bullish setup: MACD line -0.05597, signal line -0.08012, histogram +0.02414, with the status marked bullish. Price sits above the 20‑day MA ($4.7032) by +3.45% and above the 200‑day MA ($4.7117) by +3.27%, but remains below the 50‑day MA ($5.2117) by -6.64%. Key support levels are $4.2214 (S1) and $4.6496 (S2); resistance sits at $5.0058 (R2) and $5.5875 (R1).
The bid/ask spread is tight at $0.10, with 100,000 INJ of depth on both the bid and ask sides within 1% of the mid‑price, and an imbalance of zero. This indicates symmetric liquidity and minimal slippage for modest‑sized trades. The narrow spread combined with decent depth supports efficient price discovery.
Injective is an interoperable Layer‑1 blockchain focused on DeFi, offering modules for DEXs, prediction markets, lending, and cross‑chain bridging to EVM and non‑EVM chains. Development activity appears weak: github commits over the last four weeks are zero, and both Twitter followers and Reddit subscribers are reported as zero in this snapshot. These metrics raise concerns about ongoing developer engagement and community growth.
The circulating supply equals the total supply at exactly 100,000,000 INJ, meaning there is no scheduled inflation or token burn mechanism visible in the data. With a fixed supply, future price pressure will depend solely on demand dynamics rather than dilution. The fully diluted market cap therefore matches the current market cap of $486.55M.
The strongest arguments for caution are the 90.8% distance from ATH, the declining 24‑hour volume (‑9.6% vs 30‑day average), and the lack of development activity (zero GitHub commits). While the MACD is bullish and price is above key short‑ and long‑term moving averages, these positives are outweighed by weakening on‑chain interest and a stretched valuation relative to historic highs. Therefore, the prudent stance is to wait for clearer confirmation — such as a sustained volume increase or a decisive break above $5.21 with accompanying on‑chain activity — before committing new capital.
Trading Plan
🚫 Do not buy above: 5.21
🎯 Entry range: 4.70-4.80
🛑 Stop loss: 4.22
💰 Take profit: 5.59
📊 Position size: 1-2% of portfolio